Equities

Aidigong Maternal & Child Health Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Aidigong Maternal & Child Health Ltd

Actions
  • Price (HKD)1.31
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change0.00%
  • Beta0.8860
Data delayed at least 15 minutes, as of Mar 04 2026.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Aidigong Maternal & Child Health Ltd is an investment holding company primarily providing postpartum care services. The Company operates its business through three segments. The Postpartum Care segment provides maternal and infant health care services. The Health Industry segment engages in medical anti-aging, health industry investment and medical property development. The Other segment engages in investment and financing.

  • Revenue in HKD (TTM)522.09m
  • Net income in HKD-192.96m
  • Incorporated1990
  • Employees1.34k
  • Location
    Aidigong Maternal & Child Health LtdRoom 2709-10, 27th Floor, North Tower,Concordia Plaza,No1 Science Museum Road,Tsim Sha Tsui, Kowloon Hong KongHKG
  • Phone+852 26206623
  • Fax+852 26206679
  • Websitehttp://www.adg00286.hk/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.